Then it is no longer a double blind trial and will have lost all credibility.
For all our sake I hope you are wrong as if this is the case and this gets out, the trial will be discredited and will not be accepted as 'evidence based' by its piers. We have come too far to allow this to happen at this time. I find this prospect very disheartening and it gives me less confidence in this company.
Ann: EAP for Remestemcel-L in Children with MIS-C due to COVID-19, page-109
-
- There are more pages in this discussion • 317 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
-0.040(3.76%) |
Mkt cap ! $1.170B | |||
| Open | High | Low | Value | Volume |
| $1.07 | $1.07 | $1.01 | $13.19M | 12.81M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 61090 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 239558 | 5 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |